Literature DB >> 11890078

High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft.

A C Browne1, M Vearncombe, R G Sibbald.   

Abstract

Diabetic neuropathic foot ulcers are a major healthcare burden. These chronic wounds always have a bacterial load, and although normal flora is not harmful, increased tissue burden may impede healing before clinical signs of infection are evident. In this study, chronic noninfected diabetic neuropathic foot ulcers (those with adequate blood supply and pressure offloading) were assessed for bacterial burden immediately before the application of a skin substitute. Eight patients with diabetic neuropathic foot ulcers greater than 1 cm2 and free of necrotic tissue had 3-mm tissue biopsies taken from the ulcer base for quantitative bacteriology. Five of the eight patients (75%) had greater or equal to 10(5) colony forming units/gram organisms present despite the absence of clinical signs of infection. Wound healing rates were linked to bacterial load as determined from quantitative biopsy--no growth was associated with a wound healing rate of 0.2 cm per week, 10(5) to 10(6) colony forming units/gram was associated with a healing rate of 0.15 cm per week, and greater than 10(6) colony forming units/gram was associated with 0.05 cm/per week healing rate. High bacterial burden impeded healing both before and after the application of the skin substitute. The authors will change their clinical practice to assess all diabetic neuropathic foot ulcers using quantitative skin biopsies before applying skin substitutes. All patients will be treated with combination antibiotics and repeat biopsies obtained with decreased bacterial burden (< 10(6) colony forming units/gram) prior to using any bioengineered skin substitute or growth factor treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11890078

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  18 in total

1.  Biofilms and bacterial imbalances in chronic wounds: anti-Koch.

Authors:  Steven L Percival; John G Thomas; David W Williams
Journal:  Int Wound J       Date:  2010-06       Impact factor: 3.315

Review 2.  The safety and efficacy of dressings with silver - addressing clinical concerns.

Authors:  Keith Cutting; Richard White; Mike Edmonds
Journal:  Int Wound J       Date:  2007-06       Impact factor: 3.315

3.  Improved detection of clinically relevant wound bacteria using autofluorescence image-guided sampling in diabetic foot ulcers.

Authors:  Kathryn Ottolino-Perry; Emilie Chamma; Kristina M Blackmore; Liis Lindvere-Teene; Danielle Starr; Kim Tapang; Cheryl F Rosen; Bethany Pitcher; Tony Panzarella; Ron Linden; Ralph S DaCosta
Journal:  Int Wound J       Date:  2017-02-28       Impact factor: 3.315

4.  Enterococcal Metabolite Cues Facilitate Interspecies Niche Modulation and Polymicrobial Infection.

Authors:  Damien Keogh; Wei Hong Tay; Yao Yong Ho; Jennifer L Dale; Siyi Chen; Shivshankar Umashankar; Rohan B H Williams; Swaine L Chen; Gary M Dunny; Kimberly A Kline
Journal:  Cell Host Microbe       Date:  2016-10-12       Impact factor: 21.023

5.  [Significance of microbial colonisation in materials for orthopaedic technology. New insights].

Authors:  F Kipp; K Angermeier; A Koller; H H Wetz; C Hornberg
Journal:  Orthopade       Date:  2006-11       Impact factor: 1.087

6.  Reduction in wound bioburden using a silver-loaded dissolvable microfilm construct.

Authors:  Maggie Herron; Ankit Agarwal; Patricia R Kierski; Diego F Calderon; Leandro B C Teixeira; Michael J Schurr; Christopher J Murphy; Charles J Czuprynski; Jonathan F McAnulty; Nicholas L Abbott
Journal:  Adv Healthc Mater       Date:  2014-02-12       Impact factor: 9.933

Review 7.  Optimising antimicrobial therapy in diabetic foot infections.

Authors:  Nalini Rao; Benjamin A Lipsky
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Clinical efficacy of a silver-releasing foam dressing in venous leg ulcer healing: a randomised controlled trial.

Authors:  Patricia Senet; Renzo Bause; Bo Jørgensen; Karsten Fogh
Journal:  Int Wound J       Date:  2013-02-04       Impact factor: 3.315

9.  Interleukin-6 concentrations in wound fluids rather than serological markers are useful in assessing bacterial triggers of ulcer inflammation.

Authors:  Andreas Ambrosch; Ralf Lobmann; Andreas Pott; Jŭrgen Preissler
Journal:  Int Wound J       Date:  2008-01-03       Impact factor: 3.315

10.  Cultures of diabetic foot ulcers without clinical signs of infection do not predict outcomes.

Authors:  Sue E Gardner; Ambar Haleem; Ying-Ling Jao; Stephen L Hillis; John E Femino; Phinit Phisitkul; Kristopher P Heilmann; Shannon M Lehman; Carrie L Franciscus
Journal:  Diabetes Care       Date:  2014-07-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.